Eisai Awarded “The 9th Bioindustry Award” for Drug Discovery Research for Anti- Amyloid B Monoclonal Antibody Lecanemab

TOKYO, July 16, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the drug discovery research for Lecanemab (product name: "LEQEMBI®"), a humanized anti-human soluble amyloid B (AB)protofibril monoclonal antibody indicated for early Alzheimer's disease (early AD*), which was co-developed by…

BlackBerry Partners with EC-Council to Help Strengthen Malaysia’s Cybersecurity Workforce

CYBERJAYA, MALAYSIA, July 17, 2025 - (ACN Newswire via SeaPRwire.com) - BlackBerry Limited (NYSE:BB)(TSX:BB) and EC-Council, a global leader in cybersecurity certifications and learning technology, today announced a new partnership that will offer government employees nationwide with increased access to cybersecurity training and certifications through the Cybersecurity Center of Excellence (CCoE) in…

Hong Kong Picture Book Publishing Support Programme Cultivates New Creative Forces, Eight Local Illustrators Shine on the International Stage

HONG KONG, July 16, 2025 - (ACN Newswire via SeaPRwire.com) - Hong Kong's cultural and creative industries have welcomed a new wave of talent. Organized by the Innovative Entrepreneur Association (“IEA”) and sponsored by the Cultural and Creative Industries Development Agency (“CCIDA”), the Hong Kong Picture Book Publishing Support Programme…

BetOnValue Unveils Significant Platform Enhancements

BUCHAREST, Romania, July 16, 2025 — , a dynamic iGaming platform specializing in arbitrage betting and precise sports predictions, proudly announces significant service additions designed to enhance versatility and elevate the user experience. Following a series of structural and visual enhancements, BetOnValue continues to expand its offerings. Owned and operated…

Klotho Neurosciences, Inc. regains adherence to NASDAQ’s minimum bid price and stockholder equity rules.

Klotho Neurosciences Retains Listing on the NASDAQ NEW YORK, July 16, 2025 — Klotho Neurosciences, Inc. (referred to as “Klotho” or the “Company”) (NASDAQ: KLTO), a gene and cell therapy firm specializing in the treatment of neurodegenerative and other age-related conditions, today reported receiving official notification from The NASDAQ Stock…

High-Yield Stock Investment Opportunity

For investors consistently seeking profitable ventures, high-yielding dividend shares frequently stand out. A particular stock has recently drawn significant interest from both market analysts and the investment community, following a decline exceeding 10%. Although such a fall might initially appear concerning, it could signify an excellent acquisition prospect for individuals…